Saturday, 17 January 2026

Monte Carlo Portfolio Analysis: A Practical Guide to Investment Risk Assessment

Introduction: Embracing Uncertainty in Investment Decisions

In the world of finance, uncertainty is the only certainty. Traditional investment analysis often relies on single-point estimates and historical averages, but these approaches fail to capture the full spectrum of possible outcomes. Enter Monte Carlo simulation – a powerful technique that allows investors to model thousands of potential future scenarios and make more informed decisions.

In this article, we'll walk through a comprehensive case study of a three-asset investment portfolio using Monte Carlo simulation. We'll explore not just what might happen on average, but what could happen in the best and worst cases.

The Portfolio Structure: Building a Diversified Foundation

Our portfolio consists of three asset classes, each with distinct risk-return characteristics:

1. Stocks (Equities) - The Growth Engine

  • Target Allocation: 50%

  • Expected Annual Return: 8%

  • Annual Volatility: 20%

  • Role: Primary growth driver, higher risk for potentially higher returns

2. Bonds (Fixed Income) - The Stability Anchor

  • Target Allocation: 30%

  • Expected Annual Return: 4%

  • Annual Volatility: 8%

  • Role: Income generation and risk reduction

3. Real Estate (Alternative Investment) - The Diversifier

  • Target Allocation: 20% (implied as remainder)

  • Expected Annual Return: 6%

  • Annual Volatility: 15%

  • Role: Inflation hedge and additional diversification

The Monte Carlo Methodology: How We Simulate Reality

Monday, 12 January 2026

Case Study: Coffee Shop Daily Revenue Prediction using MC2D Simulator

This example demonstrates how even small businesses can benefit from probabilistic forecasting.

The Problem:
A coffee shop wants to predict its daily revenue to better manage inventory, staffing, and cash flow. The owner has observed patterns but needs a systematic way to account for variability in customer behavior.

Key Sources of Uncertainty:

  1. Customer Arrivals: Weekdays see more customers than weekends
  2. Order Size: Some customers just want coffee, others buy pastries or full breakfasts
  3. Spending per Order: Prices vary from a simple espresso to specialty drinks

The Monte Carlo Approach:
We'll model each source of uncertainty with probability distributions based on historical data:

  • Customer arrivals follow a Poisson distribution (common for counting events over time)
  • Order types follow a categorical distribution (empirical probabilities)
  • Spending follows a triangular distribution (minimum, most likely, maximum)

Insights Gained:
By running thousands of simulations, we can answer questions like:

  • What's the probability of making less than $500 on a given day?
  • What revenue range should we expect 95% of the time?
  • How does weekend vs. weekday revenue differ?

Business Applications:

  1. Staff Scheduling: Knowing revenue distributions helps optimize labor costs
  2. Inventory Management: Predicting coffee and pastry needs reduces waste
  3. Financial Planning: Understanding revenue variability aids cash flow management

Monte Carlo simulation transforms guesswork into data-driven decision making. Even with limited data, we can build models that capture essential uncertainties and provide actionable insights for small business owners.

The template file can be downloaded from this link. You can load this template and run in MC2D Simulator (This is one dimensional simulation and will work in the free version. Please adjust: Number of Variability Iterations:1000 and Number of Uncertainty Iterations: 1). The summary of the Revenue Forecasting Analysis report based on that simulation has been described below:

Case Study: Pharmaceutical Drug Manufacturing Risk Assessment Using MC2D Simulator

Overview

This Monte Carlo simulation models the manufacturing process of pharmaceutical tablets, focusing on potency variation risk assessment. It implements a Quality by Design (QbD) approach following ICH Q9 guidelines, simulating variability across the entire manufacturing process from API characterization to final tablet quality.

Process Stages Modeled:

  1. API Characterization (Input)
  • API Potency: Target 99.5% with uncertainty in analytical method (0.5-2.0% RSD)
  • API Purity: Normal distribution around 99.8% (from supplier CoA)
  • Particle Size: Log-normal distribution affecting dissolution and blending
  1. Blending Process
  • Blend Time: Uniform distribution (10-20 minutes) - critical process parameter
  • Blend Uniformity: Exponential improvement with mixing time
  • Blend Potency: Combines API potency with mixing efficiency and random variation
  1. Granulation Process
  • Moisture Content: Normal distribution around optimal 3.5% LOD (loss on drying)
  • Granule Growth: Particle size increases with moisture deviation
  • Flowability: Affected by moisture control - critical for tablet compression
  1. Compression Process
  • Tablet Weight: Normal distribution (500mg ± 10mg)
  • Tablet Hardness: Normal distribution (80N ± 8N)
  • Process Variations: Weight and hardness variations during compression
  1. Coating Process
  • Coating Thickness: Normal distribution (30μm ± 3μm)
  • Coating Uniformity: Decreases with thickness variation
  • Weight Gain: Additional weight from film coating affects final potency
  1. Quality Risk Assessment
  • Final Potency: Adjusted for coating weight gain
  • Specification Limits: 95-105% of label claim (standard pharmacopeial limits)
  • OOS Probability: Probability of out-of-specification tablets
  • Dissolution Rate: Correlates with potency - affects bioavailability
  • Batch Acceptance: Probability batch meets all quality criteria

Key Risk Metrics:

  1. Potency Deviation: Absolute deviation from 100% target
  2. OOS Probability: Risk of tablets outside 95-105% specification
  3. Batch Acceptance Rate: Overall probability of batch meeting all quality attributes
  4. Process Capability: Implicit through variation modeling

Risk Questions:

  1. "What's the probability our batch will fail potency specifications?"
  2. "How much blending time is needed to ensure content uniformity?"
  3. "What's the impact of API particle size variation on dissolution?"
  4. "How sensitive is final potency to coating thickness variation?"
  5. "What's our expected batch acceptance rate given current process capability?"

This model provides a foundational framework for pharmaceutical quality risk assessment that can be customized for specific products, processes, and quality requirements. It demonstrates how Monte Carlo simulation can bring quantitative rigor to pharmaceutical quality systems while supporting regulatory expectations for risk-based approaches.

The template file can be downloaded from this link. You can load this template and run in MC2D Simulator (Requires Premium Version). The summary of the Risk Assessment report based on that simulation has been described below:

Featured post

INTRODUCTION ARTICLE

Introducing MC2D Simulator: A Game-Changer in Risk Assessment ...